Table 3.
Bacteria | Toxins | NDOs | Mechanism of Action | Ref. |
---|---|---|---|---|
Escherichia coli | Stx, LTs, STs | Pooled HMOs, 3′SL, 6′SL, DSLNT, 6SLN, 3′S3FL, LST a | Inhibition of hemagglutination | [114] |
Fucosylated HMOs | Anti-adhesive effect | [115] | ||
Pooled HMOs, 3-FL, 3′SL, 6′SL, acidic and neutral (HMW and LMW) HMOs | Anti-adhesive effect | [116] | ||
2′FL, 3-FL | Anti-adhesive effect | [117] | ||
2′FL, 6′SL | Anti-adhesive effect | [118] | ||
Pooled HMOs | Reduced enteropathogenic E. coli (EPEC) attachment to epithelial cells | [119] | ||
AOS | Inhibition of biofilm formation | [120] | ||
COS | Antimicrobial effect | [121] | ||
Anti-adhesive effect | [122] | |||
Antibacterial effect | [123,124] | |||
(growth inhibition) | ||||
Antioxidant and antimicrobial effect | [125] | |||
Membrane disruption (growth inhibition) | [126] | |||
GOS | Anti-adhesive effect | [127] | ||
MOS | Anti-adhesive effect | [128,129] | ||
POS | Growth inhibition | [130] | ||
Anti-adhesive effect | [131] | |||
Antimicrobial effect | [132,133] | |||
Vibrio cholerae | CT | Pooled HMOs | Anti-adhesive effect (neutral, HMW) | [116] |
Isolated HMOs | No anti-adhesive effect (LMW) | [116] | ||
COS, NAc-COS | Bactericidal effect | [134] | ||
Bacillus cereus | Hbl, Nhe, CytK | COS | Antibacterial effect | [134,135] |
(growth inhibition) | ||||
Membrane disruption (growth inhibition) | [126] | |||
Staphylococcus aureus | SEs | Pooled HMOs | Inhibition of biofilm formation | [105] |
COS | Antibacterial effect | [123,134,136] | ||
(growth inhibition) | ||||
Antioxidant and antimicrobial effect | [125] | |||
POS | Growth inhibition | [130] | ||
Antimicrobial effect | [132] | |||
Anti-adhesive effect | [137] | |||
XOS | Antibacterial effect | [138] | ||
Clostridium spp. | TcdA, TcdB, CDT, CPE, CPB | FOS | Anti-adhesive effect Inhibition of biofilm formation |
[139] |